- An Electronic Medical Record (EMR) used in a consistent and meaningful way across the accountable care enterprise to document patients’ healthcare status and treatment and support safe, evidence based care.
- A Health Information Exchange (HIE) to enable the sharing of patients’ clinical data across disparate EMRs in the accountable care enterprise.
- An Activity Based Costing (ABC) system to enable detailed, patient-specific collection of cost data that in turn enables the accountable care organization to precisely understand cost of production and revenue margins in capitated payment models.
- A Patient Reported Outcomes (PRO) system to enable the complete understanding of clinical outcomes and quality, from the patient’s perspective. This is not a patient satisfaction system—it is a clinical outcomes assessment system, tailored to the patient and their protocols of treatment.
- An Enterprise Data Warehouse (EDW), which is central to enabling the analysis of data collected in the information systems described above—and more. Without the EDW, the data collection systems described above are relegated to small or non-existent ROI. It is the exposure and integration of the data in the EDW that liberates the ROI from those systems. It is common for EDWs to realize an ROI as high as 450% in two years.
Tuesday, July 30, 2013
More and more, healthcare is molded and critically impacted by the software and information technology that surrounds and supports the industry. As a consequence, the C-level suite beyond the CIO must actively participate in the evolution of their organization’s IT strategy, particularly at the layer of technology where software directly supports workflows and business processes.
There are five information systems that are indispensable to the success of an Accountable Care Organization (ACO). Those five critical information systems are listed below.
Over the past seven years, significant national policy and strategy attention was focused on EMR and HIE adoption, but very little attention has been paid to the other three components of ACO IT described above. As evidenced by the recent departure of several organizations from the Pioneer ACO program, the inability to integrate and analyze data in an EDW is “the single most frustrating issue” those organizations face. Even less national attention is being paid to the development and adoption of systems to collect detailed cost accounting data—Activity Based Costing and Patient Reported Outcomes data. Without the former, C-levels cannot accurately measure the true cost of care and the risks of capitated payments. Without the latter—Patient Reported Outcomes data—C-levels cannot accurately understand patient- and protocol-specific clinical quality. Also, precise predictive analytics and patient risk stratification is unachievable without patient reported outcomes.
At the center of these data collection systems is the EDW—the platform that enables the analysis of clinical, financial, and patient reported data in a single database repository. The EDW is the system that drives the Return in the ROI of healthcare IT for the ACO.
The term ACO is used here in a broader sense, beyond the burdensome federal definition. In this context, the term ACO implies very simply to the shift in reimbursement from procedure-based, fee-for-service towards fee-for-quality, disease, or condition-based reimbursement with capitated payments to healthcare delivery organizations on a per-case and per-capita basis. I also imply strongly that the governance structure of the accountable organization offers an insurance plan alongside healthcare delivery services, under a single CEO and Board. A quick assessment of the most successful U.S. healthcare systems, such as Intermountain Healthcare, reveals one very simple common trait: They offer health insurance plans and health delivery services under a single CEO who balances the economics of care with access to care and quality of care.
Federal funding has essentially guaranteed the industry’s adoption of EMRs and HIEs. One could argue that the quality of the products underwritten by federal incentives (e.g., Meaningful Use) and grants is mediocre at best, but, nonetheless, some version of these products is necessary to electronically collect and share patient care data. There is little argument in opposition to that concept. But, despite the investment in EMRs and HIEs, our national health strategy has not gone far enough in its encouragement of IT adoption. The EDW is the most important link in the chain of IT products required for accountable care.
In the past six years, the U.S. healthcare industry experienced an unprecedented investment in software and technology, particularly EMRs and HIEs. Conservative estimates place that investment at over $100 billion. Despite those massive investments, there is no compelling or defendable evidence of any notable return on investment. The needle is not moving on the dashboard of U.S. quality of care nor per capita cost of care. To worsen the bleak picture, physician satisfaction with the EMR products stimulated by these federal incentives is only 39% and declining—six out of 10 physicians are dissatisfied with the EMR they must use to support the treatment of their patients. Seventy-eight percent of public HIEs fail due to financial insolvency after federal and state grant monies are removed from the model. One-third of the organizations in the CMS Pioneer ACO Program are dropping out because, despite their investments in EMRs and HIEs, these organizations are unable to adequately quantify the quality of care and financial risk for managing patients in the ACO.
The federal policy and financial incentives for increasing the adoption of EMRs and HIEs was nearsighted. Without an investment in the software and technology of an EDW, the healthcare industry will not reap any worthy benefits from the investment in EMRs and HIEs.
Unlike the ROI track record of EMRs and HIEs, EDWs have consistently shown GAAP-certified, double and triple digit ROI in under two years. In other industries, the average ROI from an EDW is 431% over five years. At Intermountain Healthcare, the EDW that my team and I designed and implemented with a late binding architecture, was assessed in 2004 by a GAAP-certified 3rd party and the results were amazing—1,468% ROI in less than two years. Allina Healthcare’s EDW was recently assessed for ROI and that very conservative case study revealed a 52% ROI in 18 months.
Surprisingly, and despite these impressive ROI results, our national strategy for the computerization of healthcare stopped one step short of effective. It’s not enough for us to invest in EMRs and HIEs. Less than 25% of healthcare organizations have any type of EDW and less than 10% of those few organizations are operating consistently at Level 5 of the Healthcare Analytic Adoption Model, summarized in the figure below. C-level executives need to invest in EDWs on their own, and those healthcare organizations that do so will soon be in a position to distance themselves from competitors and the mediocrity of the current U.S. healthcare market.
Organizations like Intermountain Healthcare and Allina have been operating on their own as accountable care organizations for decades, without federal incentives for IT investments and without the complicated business model and administrative overhead of a CMS ACO. They understand the value of an EDW in maximizing the quality-cost ratio of healthcare delivery. If you want to be an ACO—federal or otherwise—follow their role model.
Although the healthcare industry is progressing in its adoption of information technology to enable healthcare that is accessible, affordable, and measurable, we are overlooking three of the five most important IT investments necessary for accountable care—i.e., the EDW, activity based cost accounting systems, and patient reported outcomes systems. Vendors are not yet offering products that support activity based costing or patient reported outcomes. The lack of these products is a significant gap in our national health data strategy, but also an opportunity for entrepreneurs to develop highly valued products.
The EDW will enable a deep understanding of care quality, variations in care, and costs of care. The EDW market is emerging, with over 40 vendors offering various products in this segment. In the next three years, we will see major market consolidation and shakeout, similar to that seen with EMR vendors. At the end of this consolidation period, I predict six vendors will remain standing that are capable of supporting analytics up to Level 8 in the Analytic Adoption Model. Unfortunately, healthcare executives cannot wait three years for the market to consolidate. Market forces are accelerating the need for analytics as a tool to survive, first, and thrive, second. C-levels must choose a partner now and hope that the partner they choose can provide a solution that will survive the shakeout.
There are three principles of information technology that are common across industries. As healthcare becomes a more tech-savvy, computerized industry, it’s important for healthcare executives beyond the CIO to understand these principles and their impact on the business.
Information technology—specifically software—is now the dominant variable in business agility and adaptability. In the past, the dominant variables were the culture and skills of the people of the organization. But even the best, most talented employees can perform their jobs no better and no faster than the functionality of the software and information technology that surrounds them. The best software and information technology can drive unprecedented business insight and business models. The worst software can drive a business into the ground. Accepting this principle implies that business leaders in the C-level must engage themselves in the strategy and decisions about their organization’s software acquisitions and configurations to an unprecedented level of detail.
The software and underlying technology that enables the analysis of patterns in large data sets is also enabling extraordinary new ability for businesses to identify opportunities for greater efficiency, higher quality, lower overhead, higher margins, and new products. Big data, business intelligence, analytics—these are all buzzword synonyms used to describe the same underlying combination of software and technology—that is, the EDW.
Every industry passes through three phases of data management maturity. Phase 1 is the Data Collection Phase. Data is collected in a transaction workflow system, such as a point-of-sale system, to support a particular workflow (i.e., a purchase). Phase 2 is the Data Sharing Phase. The data that is collected in the transaction systems of Phase 1 is shared with other downstream data collection systems and workflows, such as a general ledger or supply chain management system. Phase 3 is the Data Analysis Phase. In this Phase, the data that is collected and shared to support specific transactions and workflows in Phases 1 and 2 is aggregated across thousands and millions of those individual transactions to analyze macroscopic patterns in the data. In healthcare, Phase 1 is characterized by registration, scheduling, laboratory, and electronic medical record (EMR) systems. Phase 2 is characterized by the implementation of health information exchanges. Phase 3, barely underway, is characterized by the implementation of the EDW.
I had a recent opportunity to engage in an online discussion with a well-known healthcare analytics vendor about the value of comparative analytics, predictive analytics, and natural language processing (NLP) in healthcare. This vendor was describing a beautiful new world of the future, in which comparative data in particular would be the cornerstone of our industry’s turnaround. The executive summary of my response: Beware the smoke and mirrors.
My full response is below.
We’ve had comparative data for years in the US healthcare system and it hasn’t moved the needle toward the better, at all. In fact, the latest OECD (Organisation for Economic Cooperation and Development) data rank the US worse than we’ve ever been in healthcare quality and cost. Comparative data, like the OECD, is interesting and certainly worth looking at, but it’s far from enough to drive improvements in an organization down to the individual patient. To drive that sort of change, you have to get your head and hands dirty in your own data ecosystem — not somebody else’s that is, at best, a rough facsimile of your organization.
There are too many variables and variations in healthcare delivery right now that add too much noise to the data to make comparative analytics as valuable as some pundits advocate. We don’t even have an industry standard and clinically precise definition of patients that should be included (and excluded from routine management) in a diabetes registry, much less the other 15 chronic diseases and syndromes we should be managing.
We’ve also had predictive analytics supporting risk stratification for years in healthcare, particularly in case management. But without outcomes data, what are we left to predict? Readmissions. That’s a sad state of affairs. Before we start believing that predictive analytics is going to change the healthcare world, we need to understand how it works, technically and programatically. Without protocol and patient specific outcomes data, predictive analytics is largely vendor smoke and mirrors in all but a very small number of use cases.
We’ve had NLP for years in healthcare as well, with essentially no impact on the industry. When I joined healthcare, I brought with me a deep background in NLP and predictive analytics from the military, national intelligence, and credit reporting environments, in hopes that we could revolutionize the industry. We’ve made incremental progress, but there are fundamental gaps in our industry’s data ecosystem — missing pieces of the data puzzle — that inherently limit what we can achieve with NLP.
Google revolutionized the world of NLP, but Google leveraged a metadata ecosystem that is layered on top of traditional NLP strategies to achieve the revolution. In healthcare, we don’t have the same metadata ecosystem within the current generation of EMRs, much less across EMRs. In today’s EMRs, we have little more than expensive word processors. I keep hoping that the Googles, Facebooks, and Amazons of the world will quietly build a new generation EMR, but with $29B in federal money now squandered on our existing generation of EMRs, there’s very little motivation in the market for innovation.
Does my cynicism and caution imply that we should turn away from comparative data, predictive modeling, or NLP? Absolutely not. I’ve been advocating these analytic tools in healthcare for 17 years. It implies that we should take advantage of the easy value analytic victories, first. Don’t chase the asymptote. Don’t chase the latest fad and vendor hype. Deliberately, but quickly, move your organization up the levels of the Analytic Adoption Model. It’s going to take at least five years, maybe longer, and a new generation of EMRs, patient reported outcomes systems, and activity based cost accounting systems before we can close the gaps in our data ecosystem to make predictive models and NLP widely valuable in the industry.
Comparative data will not be as valuable as it should be until we squeeze the variability out of our healthcare practices and standardize our data definitions of diseases and syndromes. If that happens in five years, I’d be pleasantly amazed. Variability analysis, not benchmarking, might be the most useful application of comparative data in our current healthcare environment.
Beware the vendors that oversell what’s possible, my friends. We are in the uphill climb of the hype cycle right now.
This article , entitled, "23 Dangerous Things You Should Let Your Kids Do", prompted me to pause and think. Here are the 23 things...
Population health isn’t as complex or novel an idea as some people make it out to be. We're wringing our hands and making it more comp...
Amazing...This is a picture of Vic Sundquist, 95 years old, in the log cutting contest at the Dolores, Colorado Escalante Days celebration ...
This is an entry for our little girl, Anna, and our soon-born son, due January 22, 2016. In this picture is my only brother, Gene Sanders,...